Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 708 (USA) (Dr. Kim)
· consented 2013-09-10
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild ABDOMINAL PAIN — outcome: RECOVERED/RESOLVED; onset 2014-02-18 (study day 162.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-12 (study day 3.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild CONSTIPATION — outcome: RECOVERED/RESOLVED; onset 2014-02-18 (study day 162.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-23 (study day 14.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.